Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02285283 · ClinicalTrials.gov registry record · Phase 2
Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 58
- Enrollment target
NCT02285283 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 58 participants.
The verdict
NCT02285283, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled double-blinded trial is to determine if the addition of an oral antifungal to typical post-operative medical therapy can prevent or reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Interventions
- DRUG Placebo
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-05-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02285283
The ClinicalTrials.gov registry entry for NCT02285283 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02285283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02285283 about?
NCT02285283 is a clinical study titled "Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps". The purpose of this randomized controlled double-blinded trial is to determine if the addition of an oral antifungal to typical post-operative medical therapy can prevent or reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic rhinosinusitis with nasal polyps ...
What is the current status of trial NCT02285283?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 58 participants. The study started on 2014-11. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT02285283?
The interventions under investigation include: Placebo (DRUG), Itraconazole (DRUG).
Who is sponsoring clinical trial NCT02285283?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.